borderline significancep = 0.050
ΔSIRI showed borderline significance ( p = 0.050).
ΔSIRI showed borderline significance ( p = 0.050).
The study reported the relative risk of PCa when seropositive for HPV18 as 2.59 (CI 95% = 1.17–5.75) and found the association between HPV18 and PCa to be highly significant ( p < 0.05) [ 81 ].
BRAF mutation burden ( p = 0.001- post estimation by Pearson χ2 goodness-of-fit test p = 0.4) depended significantly on age at diagnosis ( p = 0.001) and in borderline significance on the anatomical site where CM developed ( p = 0.05).
In contrast, a study conducted on breast cancer reported a marginally significant reduction ( p = 0.05) in FTO gene expression in the breast tissue of patients with the AA homozygous genotype [ 54 ].
Treatment protocols revealed a borderline significant difference ( p = 0.05).
In the multivariate analysis of this group of patients, only VEGF-C overexpression showed an independent impact on worse prognosis, with a borderline significance value ( p = 0.05, CI 95%: −0.03–3.99, HR: 7.2). 4.
A constant increase in intracellular production was observed in CD3, CD3/CD4, and CD3/CD8 cells, which became highly significant already at T3d for IFNγ ( p < 0.05) and at T7d for TNFα ( p < 0.005), and increased further at later time points ( Figure 4 A,B).
Additionally, most of the detected miRNAs, including the selected miR-150-5p and miR-23b-3p, did not reach the conventional significance threshold of adjusted p -values < 0.05, but they showed a trend toward significance with p < 0.05.
Patients who had not received (β = 1.05) or who completed RT (β = 1.08), showed a better SumSc score compared to those who were receiving RT, but with a borderline significance ( p = 0.05) ( Table 5 ). 4.
observed an increasing trend associated with tumor shrinkage ( p < 0.05) in the course of NACT and a higher cfDI in eBC patients exposed to NACT who achieved pCR at surgery [ 125 ].
SDRs due to ovarian cancer showed a decreasing trend between 2007 and 2021 (APC = −0.5%, p < 0.05).
After correction, the model remained significantly associated with survival in oligodendrogliomas (FDR = 0.0030), while a trend toward significance was observed in IDH-mutant astrocytomas (unadjusted p < 0.05, FDR = 0.052).
An absence of primary osteosarcoma metastases was of borderline significance for both overall ( p = 0.050) and event-free ( p = 0.063) survival. 4.
Although there was a trend towards lower pneumonectomy rates in patients treated with chemoimmunotherapy, the difference did not reach statistical significance (OR: 0.76, 95% CI: 0.57–1.00, p = 0.0500) ( Figure S6 ).
However, we did identify a near-significant ( p = 0.050) association between the presence of a solid growth pattern and low-risk tumors.
Among echocardiographic parameters, RVSP > 39 mmHg was a negative predictor (HR = 2.01), while RVSP < 21 mmHg and RV free wall strain < −30% were positive predictors (HR = 0.36 and HR = 0.56, respectively), whereas RV GLS < −25.5% had a borderline significance (HR = 0.59; p = 0.05).
In multivariate analysis, the number of TREM2 + immune cells was marginally significant ( p = 0.05).
Similarly, when OS was considered, statistically significant differences for T2WI, DWI, and MR consensus were observed, with PET/MR consensus lying at the threshold of significance ( p = 0.05).
We performed a test for ES to evaluate whether the number of studies reporting nominally significant results ( p < 0.05) was greater compared to the expected number of studies reporting statistically significant results [ 29 ].
A borderline significant difference was found in blast percentage ( p = 0.05), with more patients in the WT1 high group having blast counts ≥80%.
Moreover, we found that higher expression of SST 5 showed a trend for a lower incidence of both local and regional recurrence ( p = 0.05) ( Table 1 ).
Interestingly, borderline significance ( p = 0.05) was observed for lymph node metastasis.
Healthy nonsmokers exhibited the highest cumulative number of unique reads among all study groups ( Figure 1 D), with a borderline significance ( p = 0.05) compared to healthy smokers.
One study showed a trend toward increased risk with prior WBRT ( p = 0.05).
There is a trend toward significance according to Fearon’s criteria (HR 2.3; 95% CI [1.00–5.27]; p = 0.05).